T. Rowe Price Investment Management, Inc. Avid Bioservices, Inc. Transaction History

T. Rowe Price Investment Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$4.64 - $9.56 $1.18 Million - $2.42 Million	253,385 Added 6.18%	4,352,252 $28.3 Million
Q3 2023 Nov 14, 2023	BUY	$9.4 - $14.04 $1.72 Million - $2.57 Million	183,000 Added 4.67%	4,098,867 $38.7 Million
Q2 2023 Aug 14, 2023	BUY	$12.96 - $20.93 $2.31 Million - $3.73 Million	177,981 Added 4.76%	3,915,867 $54.7 Million
Q1 2023 May 15, 2023	BUY	$13.48 - $18.79 $1.76 Million - $2.45 Million	130,233 Added 3.61%	3,737,886 $70.1 Million
Q4 2022 Feb 14, 2023	BUY	$12.61 - $18.74 $24.8 Million - $36.8 Million	1,965,560 Added 119.7%	3,607,653 $49.7 Million
Q3 2022 Nov 14, 2022	BUY	$15.33 - $20.36 $25.2 Million - $33.4 Million	1,642,093 New	1,642,093 $31.4 Million

184

67.8M

89.9K

118K

Ticker CDMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,167,500
Market Cap $770M
Description
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...

Get notified when there are updates to the investment portfolio of T. Rowe Price Investment Management, Inc., based on Form 13F filings with the SEC.

Stay updated on T. Rowe Price Investment Management, Inc. with notifications on news.